Evidence map›Paper›PMID 33283280›Full record

ArticleImmunology2021

The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia.

Sudan Tao, Katherine M Kichula, Genelle F Harrison, Ticiana Della Justina Farias, William H Palmer, Laura Ann Leaton, Che Ghazali Norul Hajar, Zulkafli Zefarina, Hisham Atan Edinur, Faming Zhu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. High-Resolution Characterization ofFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Sudan TaoDivision of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Katherine M KichulaDivision of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Genelle F HarrisonDivision of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-3386-8159
Ticiana Della Justina FariasDivision of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-3606-2428
William H PalmerDivision of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-0348-6339
Laura Ann LeatonDivision of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Che Ghazali Norul HajarSchool of Health Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.ORCID 0000-0001-5152-1883
Zulkafli ZefarinaSchool of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.ORCID 0000-0003-2029-2234
Hisham Atan EdinurSchool of Health Sciences, Universiti Sains Malaysia, Health Campus, Kelantan, Malaysia.ORCID 0000-0002-3379-6063
Faming ZhuBlood Center of Zhejiang Province, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, Zhejiang, China.
Paul J NormanDivision of Biomedical Informatics and Personalized Medicine, Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-8370-7703
University of Colorado Anschutz Medical Campus · USUniversiti Sains Malaysia · MYBlood Center of Zhejiang Province · CN

Funding

University of Colorado Anschutz Medical Campus DRCP30DK116073 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LORI SUSSEL · 2020 to 2026
$10.8M
Evolution and Function of Immunogenetic Diversity across the Eastern HemisphereR01AI151549 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Paul John Norman · 2022 to 2026
$3.9M
Evolution and Function of Immunogenetic Diversity Across the Eastern HemisphereR56AI151549 · NIAID · UNIVERSITY OF COLORADO DENVER · PI NORMAN, PAUL JOHN · 2020 to 2020
$387k
NIAID NIH HHS R01 AI151549NIAID NIH HHS R56 AI151549NIDDK NIH HHS P30 DK116073
6 · The paper itself

Abstract

Killer cell immunoglobulin-like receptors (KIRs) interact with polymorphic human leucocyte antigen (HLA) class I molecules, modulating natural killer (NK) cell functions and affecting both the susceptibility and outcome of immune-mediated diseases. The KIR locus is highly diverse in gene content, copy number and allelic polymorphism within individuals and across geographical populations. To analyse currently under-represented Asian and Pacific populations, we investigated the combinatorial diversity of KIR and HLA class I in 92 unrelated Malay and 75 Malaysian Chinese individuals from the Malay Peninsula. We identified substantial allelic and structural diversity of the KIR locus in both populations and characterized novel variations at each analysis level. The Malay population is more diverse than Malay Chinese, likely representing a unique history including admixture with immigrating populations spanning several thousand years. Characterizing the Malay population are KIR haplotypes with large structural variants present in 10% individuals, and KIR and HLA alleles previously identified in Austronesian populations. Despite the differences in ancestries, the proportion of HLA allotypes that serve as KIR ligands is similar in each population. The exception is a significantly reduced frequency of interactions of KIR2DL1 with C2

Indexed as

Asian PeopleGenotypeNative Hawaiian or Pacific IslanderAllelesDNA Copy Number VariationsFemaleGene FrequencyGenetic Predisposition to DiseaseGenetic VariationHigh-Throughput Nucleotide SequencingHLA-C AntigensHumansIncidenceMalaysiaMalePre-EclampsiaHLA-C AntigensKIR2DL1 protein, humanReceptors, KIR2DL1genetic diversityHLAKIRMalaysiaNatural killer (NK) cells

Identifiers

PMID33283280
PMCPMC7968402
OpenAlexW3112023066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.